Episode 308: 307. Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES)

Questioning Medicine

English - June 25, 2024 00:00 - 5 minutes - 6.21 MB - ★★★★★ - 68 ratings
Medicine Health & Fitness health education medicine hospital general family health & fitness Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Episode 307: 306. METHODS MONDAY! What is the 95% Confidence Interval?

Next Episode: Episode 309: 308. Mailed feedback to Primary Care Physicians on Antibiotic Prescribing

Kityo C et al. Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): Week 48 results from a randomised, multicentre, open-label, non-inferiority trial. Lancet Infect Dis 2024 May 28; [e-pub]. (https://doi.org/10.1016/S1473-3099(24)00289-5)307